HEADER CELL ADHESION 27-JUL-16 5L0G TITLE HUMAN METAVINCULIN MVT Q971R, R975D, T978R MUTANT (RESIDUES 959-1134) TITLE 2 IN COMPLEX WITH PIP2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: VINCULIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: UNP RESIDUES 959-1134; COMPND 5 SYNONYM: METAVINCULIN,MV; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: VCL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS 5-HELIX BUNDLE, CYTOSKELATAL PROTEIN, PHOSPHOLIPIDS, CELL ADHESION, KEYWDS 2 STRUCTURAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.CHINTHALAPUDI,T.IZARD REVDAT 4 04-OCT-23 5L0G 1 LINK REVDAT 3 01-NOV-17 5L0G 1 JRNL REMARK REVDAT 2 07-SEP-16 5L0G 1 JRNL REVDAT 1 31-AUG-16 5L0G 0 JRNL AUTH K.CHINTHALAPUDI,E.S.RANGARAJAN,D.T.BROWN,T.IZARD JRNL TITL DIFFERENTIAL LIPID BINDING OF VINCULIN ISOFORMS PROMOTES JRNL TITL 2 QUASI-EQUIVALENT DIMERIZATION. JRNL REF PROC.NATL.ACAD.SCI.USA V. 113 9539 2016 JRNL REFN ESSN 1091-6490 JRNL PMID 27503891 JRNL DOI 10.1073/PNAS.1600702113 REMARK 2 REMARK 2 RESOLUTION. 3.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 9571 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 473 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.80 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.72 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2731 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2010 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2593 REMARK 3 BIN R VALUE (WORKING SET) : 0.1973 REMARK 3 BIN FREE R VALUE : 0.2750 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.05 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 138 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5300 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 46 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 86.68 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 96.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.17430 REMARK 3 B22 (A**2) : 3.17430 REMARK 3 B33 (A**2) : -6.34860 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.744 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.598 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.890 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5416 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7304 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2735 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 140 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 762 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5416 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 783 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6399 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.14 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.63 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 3.15 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5L0G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JUL-16. REMARK 100 THE DEPOSITION ID IS D_1000222729. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-OCT-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300-HS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9632 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.400 REMARK 200 RESOLUTION RANGE LOW (A) : 96.570 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 11.10 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 11.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3MYI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 3350, 2% TRYPTONE, AND 0.05 M REMARK 280 HEPES, PH 7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 128.75467 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 64.37733 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: DIMER CONFIRMED BY IN VITRO FRET ANALYSIS REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 98.48094 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 64.37733 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 98.48094 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 64.37733 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 959 REMARK 465 ARG A 1076 REMARK 465 TYR A 1133 REMARK 465 GLN A 1134 REMARK 465 ASP B 1119 REMARK 465 ALA B 1120 REMARK 465 TYR B 1133 REMARK 465 GLN B 1134 REMARK 465 ASP C 1119 REMARK 465 ALA C 1120 REMARK 465 GLY C 1121 REMARK 465 TYR C 1133 REMARK 465 GLN C 1134 REMARK 465 ARG D 1076 REMARK 465 THR D 1077 REMARK 465 ASP D 1119 REMARK 465 ALA D 1120 REMARK 465 GLY D 1121 REMARK 465 GLN D 1134 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A1122 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE B1122 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE C1122 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE D1122 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CE LYS C 1012 O ALA C 1071 2.04 REMARK 500 CD LYS B 1012 O ALA B 1071 2.17 REMARK 500 O ALA C 999 OG SER C 1002 2.19 REMARK 500 OE1 GLU C 976 CG LYS C 1103 2.19 REMARK 500 NH2 ARG B 1003 O HOH B 1301 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU C 1083 NZ LYS D 1064 3675 1.64 REMARK 500 OE2 GLU C 1083 CE LYS D 1064 3675 1.87 REMARK 500 CA GLY A 1008 OD2 ASP A 1119 1565 2.03 REMARK 500 N GLY A 1008 OD2 ASP A 1119 1565 2.08 REMARK 500 CB ALA B 1111 NH2 ARG D 1044 3675 2.17 REMARK 500 NZ LYS A 1064 OE2 GLU B 1083 2764 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 983 108.50 -57.40 REMARK 500 THR A1118 -130.27 55.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B1313 DISTANCE = 5.93 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PIO B 1201 REMARK 610 PIO C 1201 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PIO B 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PIO C 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Ligand ILE C 988 bound to ASN C REMARK 800 985 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ALA B 989 and ARG D REMARK 800 1013 DBREF 5L0G A 959 1134 UNP P18206 VINC_HUMAN 959 1134 DBREF 5L0G B 959 1134 UNP P18206 VINC_HUMAN 959 1134 DBREF 5L0G C 959 1134 UNP P18206 VINC_HUMAN 959 1134 DBREF 5L0G D 959 1134 UNP P18206 VINC_HUMAN 959 1134 SEQADV 5L0G ARG A 971 UNP P18206 GLN 971 ENGINEERED MUTATION SEQADV 5L0G ASP A 975 UNP P18206 ARG 975 ENGINEERED MUTATION SEQADV 5L0G ARG A 978 UNP P18206 THR 978 ENGINEERED MUTATION SEQADV 5L0G ARG B 971 UNP P18206 GLN 971 ENGINEERED MUTATION SEQADV 5L0G ASP B 975 UNP P18206 ARG 975 ENGINEERED MUTATION SEQADV 5L0G ARG B 978 UNP P18206 THR 978 ENGINEERED MUTATION SEQADV 5L0G ARG C 971 UNP P18206 GLN 971 ENGINEERED MUTATION SEQADV 5L0G ASP C 975 UNP P18206 ARG 975 ENGINEERED MUTATION SEQADV 5L0G ARG C 978 UNP P18206 THR 978 ENGINEERED MUTATION SEQADV 5L0G ARG D 971 UNP P18206 GLN 971 ENGINEERED MUTATION SEQADV 5L0G ASP D 975 UNP P18206 ARG 975 ENGINEERED MUTATION SEQADV 5L0G ARG D 978 UNP P18206 THR 978 ENGINEERED MUTATION SEQRES 1 A 176 ASN GLN PRO VAL ASN GLN PRO ILE LEU ALA ALA ALA ARG SEQRES 2 A 176 SER LEU HIS ASP GLU ALA ARG LYS TRP SER SER LYS GLY SEQRES 3 A 176 ASN ASP ILE ILE ALA ALA ALA LYS ARG MET ALA LEU LEU SEQRES 4 A 176 MET ALA GLU MET SER ARG LEU VAL ARG GLY GLY SER GLY SEQRES 5 A 176 THR LYS ARG ALA LEU ILE GLN CYS ALA LYS ASP ILE ALA SEQRES 6 A 176 LYS ALA SER ASP GLU VAL THR ARG LEU ALA LYS GLU VAL SEQRES 7 A 176 ALA LYS GLN CYS THR ASP LYS ARG ILE ARG THR ASN LEU SEQRES 8 A 176 LEU GLN VAL CYS GLU ARG ILE PRO THR ILE SER THR GLN SEQRES 9 A 176 LEU LYS ILE LEU SER THR VAL LYS ALA THR MET LEU GLY SEQRES 10 A 176 ARG THR ASN ILE SER ASP GLU GLU SER GLU GLN ALA THR SEQRES 11 A 176 GLU MET LEU VAL HIS ASN ALA GLN ASN LEU MET GLN SER SEQRES 12 A 176 VAL LYS GLU THR VAL ARG GLU ALA GLU ALA ALA SER ILE SEQRES 13 A 176 LYS ILE ARG THR ASP ALA GLY PHE THR LEU ARG TRP VAL SEQRES 14 A 176 ARG LYS THR PRO TRP TYR GLN SEQRES 1 B 176 ASN GLN PRO VAL ASN GLN PRO ILE LEU ALA ALA ALA ARG SEQRES 2 B 176 SER LEU HIS ASP GLU ALA ARG LYS TRP SER SER LYS GLY SEQRES 3 B 176 ASN ASP ILE ILE ALA ALA ALA LYS ARG MET ALA LEU LEU SEQRES 4 B 176 MET ALA GLU MET SER ARG LEU VAL ARG GLY GLY SER GLY SEQRES 5 B 176 THR LYS ARG ALA LEU ILE GLN CYS ALA LYS ASP ILE ALA SEQRES 6 B 176 LYS ALA SER ASP GLU VAL THR ARG LEU ALA LYS GLU VAL SEQRES 7 B 176 ALA LYS GLN CYS THR ASP LYS ARG ILE ARG THR ASN LEU SEQRES 8 B 176 LEU GLN VAL CYS GLU ARG ILE PRO THR ILE SER THR GLN SEQRES 9 B 176 LEU LYS ILE LEU SER THR VAL LYS ALA THR MET LEU GLY SEQRES 10 B 176 ARG THR ASN ILE SER ASP GLU GLU SER GLU GLN ALA THR SEQRES 11 B 176 GLU MET LEU VAL HIS ASN ALA GLN ASN LEU MET GLN SER SEQRES 12 B 176 VAL LYS GLU THR VAL ARG GLU ALA GLU ALA ALA SER ILE SEQRES 13 B 176 LYS ILE ARG THR ASP ALA GLY PHE THR LEU ARG TRP VAL SEQRES 14 B 176 ARG LYS THR PRO TRP TYR GLN SEQRES 1 C 176 ASN GLN PRO VAL ASN GLN PRO ILE LEU ALA ALA ALA ARG SEQRES 2 C 176 SER LEU HIS ASP GLU ALA ARG LYS TRP SER SER LYS GLY SEQRES 3 C 176 ASN ASP ILE ILE ALA ALA ALA LYS ARG MET ALA LEU LEU SEQRES 4 C 176 MET ALA GLU MET SER ARG LEU VAL ARG GLY GLY SER GLY SEQRES 5 C 176 THR LYS ARG ALA LEU ILE GLN CYS ALA LYS ASP ILE ALA SEQRES 6 C 176 LYS ALA SER ASP GLU VAL THR ARG LEU ALA LYS GLU VAL SEQRES 7 C 176 ALA LYS GLN CYS THR ASP LYS ARG ILE ARG THR ASN LEU SEQRES 8 C 176 LEU GLN VAL CYS GLU ARG ILE PRO THR ILE SER THR GLN SEQRES 9 C 176 LEU LYS ILE LEU SER THR VAL LYS ALA THR MET LEU GLY SEQRES 10 C 176 ARG THR ASN ILE SER ASP GLU GLU SER GLU GLN ALA THR SEQRES 11 C 176 GLU MET LEU VAL HIS ASN ALA GLN ASN LEU MET GLN SER SEQRES 12 C 176 VAL LYS GLU THR VAL ARG GLU ALA GLU ALA ALA SER ILE SEQRES 13 C 176 LYS ILE ARG THR ASP ALA GLY PHE THR LEU ARG TRP VAL SEQRES 14 C 176 ARG LYS THR PRO TRP TYR GLN SEQRES 1 D 176 ASN GLN PRO VAL ASN GLN PRO ILE LEU ALA ALA ALA ARG SEQRES 2 D 176 SER LEU HIS ASP GLU ALA ARG LYS TRP SER SER LYS GLY SEQRES 3 D 176 ASN ASP ILE ILE ALA ALA ALA LYS ARG MET ALA LEU LEU SEQRES 4 D 176 MET ALA GLU MET SER ARG LEU VAL ARG GLY GLY SER GLY SEQRES 5 D 176 THR LYS ARG ALA LEU ILE GLN CYS ALA LYS ASP ILE ALA SEQRES 6 D 176 LYS ALA SER ASP GLU VAL THR ARG LEU ALA LYS GLU VAL SEQRES 7 D 176 ALA LYS GLN CYS THR ASP LYS ARG ILE ARG THR ASN LEU SEQRES 8 D 176 LEU GLN VAL CYS GLU ARG ILE PRO THR ILE SER THR GLN SEQRES 9 D 176 LEU LYS ILE LEU SER THR VAL LYS ALA THR MET LEU GLY SEQRES 10 D 176 ARG THR ASN ILE SER ASP GLU GLU SER GLU GLN ALA THR SEQRES 11 D 176 GLU MET LEU VAL HIS ASN ALA GLN ASN LEU MET GLN SER SEQRES 12 D 176 VAL LYS GLU THR VAL ARG GLU ALA GLU ALA ALA SER ILE SEQRES 13 D 176 LYS ILE ARG THR ASP ALA GLY PHE THR LEU ARG TRP VAL SEQRES 14 D 176 ARG LYS THR PRO TRP TYR GLN HET PIO B1201 32 HET PIO C1201 24 HETNAM PIO [(2R)-2-OCTANOYLOXY-3-[OXIDANYL-[(1R,2R,3S,4R,5R,6S)-2, HETNAM 2 PIO 3,6-TRIS(OXIDANYL)-4,5-DIPHOSPHONOOXY-CYCLOHEXYL]OXY- HETNAM 3 PIO PHOSPHORYL]OXY-PROPYL] OCTANOATE HETSYN PIO DIOCTANOYL L-ALPHA-PHOSPHATIDYL-D-MYO-INOSITOL 4,5- HETSYN 2 PIO DIPHOSPHATE FORMUL 5 PIO 2(C25 H49 O19 P3) FORMUL 7 HOH *46(H2 O) HELIX 1 AA1 ASN A 963 LYS A 979 1 17 HELIX 2 AA2 ASN A 985 ARG A 1006 1 22 HELIX 3 AA3 THR A 1011 GLN A 1039 1 29 HELIX 4 AA4 ASP A 1042 MET A 1073 1 32 HELIX 5 AA5 SER A 1080 LYS A 1115 1 36 HELIX 6 AA6 ASN B 963 ARG B 978 1 16 HELIX 7 AA7 ASN B 985 GLY B 1007 1 23 HELIX 8 AA8 THR B 1011 CYS B 1040 1 30 HELIX 9 AA9 ASP B 1042 MET B 1073 1 32 HELIX 10 AB1 SER B 1080 LYS B 1115 1 36 HELIX 11 AB2 ASN C 963 ARG C 978 1 16 HELIX 12 AB3 ASN C 985 GLY C 1007 1 23 HELIX 13 AB4 THR C 1011 CYS C 1040 1 30 HELIX 14 AB5 ASP C 1042 ARG C 1076 1 35 HELIX 15 AB6 SER C 1080 LYS C 1115 1 36 HELIX 16 AB7 ASN D 963 ARG D 978 1 16 HELIX 17 AB8 ASN D 985 GLY D 1007 1 23 HELIX 18 AB9 THR D 1011 CYS D 1040 1 30 HELIX 19 AC1 ASP D 1042 MET D 1073 1 32 HELIX 20 AC2 SER D 1080 LYS D 1115 1 36 LINK CB ALA B 989 NH1 ARG D1013 1555 3775 1.31 LINK ND2 ASN C 985 CG1 ILE C 988 1555 1555 1.42 SITE 1 AC1 6 LYS A 983 SER B 982 LYS B 983 LYS B 992 SITE 2 AC1 6 LYS B1129 ARG D1013 SITE 1 AC2 8 ARG B1076 SER C 981 SER C 982 LYS C 983 SITE 2 AC2 8 LYS C 992 LYS C1129 SER D 982 LYS D 983 SITE 1 AC3 8 ASN C 985 ASP C 986 ILE C 987 ALA C 989 SITE 2 AC3 8 ALA C 990 ALA C 991 LYS C 992 TRP C1126 SITE 1 AC4 32 SER B 982 ASN B 985 ASP B 986 ILE B 987 SITE 2 AC4 32 ILE B 988 ALA B 990 ALA B 991 LYS B 992 SITE 3 AC4 32 ARG B 993 THR B1011 LYS B1012 ALA B1014 SITE 4 AC4 32 LEU B1015 ILE B1016 GLN B1017 LYS B1020 SITE 5 AC4 32 PIO B1201 ASN D 985 ASP D 986 ILE D 987 SITE 6 AC4 32 ILE D 988 ALA D 990 ALA D 991 LYS D 992 SITE 7 AC4 32 ARG D 993 THR D1011 LYS D1012 ALA D1014 SITE 8 AC4 32 LEU D1015 GLN D1017 PHE D1122 THR D1123 CRYST1 56.858 56.858 193.132 90.00 90.00 120.00 P 32 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017588 0.010154 0.000000 0.00000 SCALE2 0.000000 0.020308 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005178 0.00000